Genetics, Noonan syndrome, PTPN11, LEOPARD Syndrome and Noonan Syndrome with Multiple Lentigines are his primary areas of study. His Genetics study focuses on Missense mutation, Mutation, Autosomal dominant trait, Copy-number variation and Single-nucleotide polymorphism in particular. The various areas that Bruce D. Gelb examines in his Noonan syndrome study include RASopathy, KRAS, Cardiofaciocutaneous syndrome, SOS1 and Genetic heterogeneity.
His biological study spans a wide range of topics, including Cancer research, Germline mutation, Signal transduction, Protein tyrosine phosphatase and Juvenile myelomonocytic leukemia. The study incorporates disciplines such as Endocrinology, Internal medicine and Webbed neck in addition to Noonan Syndrome with Multiple Lentigines. His Internal medicine study integrates concerns from other disciplines, such as Surgery and Cardiology.
Bruce D. Gelb mainly focuses on Genetics, Noonan syndrome, Internal medicine, PTPN11 and Heart disease. His study in Missense mutation, Mutation, Gene, Phenotype and Allele falls under the purview of Genetics. His studies deal with areas such as RASopathy, Germline mutation, SOS1, Noonan Syndrome with Multiple Lentigines and Costello syndrome as well as Noonan syndrome.
His Internal medicine research incorporates themes from Endocrinology, Surgery and Cardiology. Bruce D. Gelb interconnects LEOPARD Syndrome, Juvenile myelomonocytic leukemia, Cancer research and Protein tyrosine phosphatase in the investigation of issues within PTPN11. His research ties Bioinformatics and Heart disease together.
Bruce D. Gelb focuses on Genetics, Heart disease, Internal medicine, Phenotype and Gene. Exome sequencing, Genome-wide association study, Somatic cell, Exome and Allele are the core of his Genetics study. His study in Heart disease is interdisciplinary in nature, drawing from both Human Induced Pluripotent Stem Cells, Proband, Cohort and Copy-number variation.
His work in Internal medicine addresses subjects such as Cardiology, which are connected to disciplines such as Haploinsufficiency. His Phenotype research is multidisciplinary, incorporating perspectives in Noonan syndrome, MAPK/ERK pathway and Bioinformatics. His Noonan syndrome research is multidisciplinary, incorporating elements of RASopathy, Signal transduction, Germline and Costello syndrome.
His primary areas of study are Genetics, Heart disease, Gene, Noonan syndrome and Disease. His Genetics research focuses on Exome sequencing, Phenotype, Genome-wide association study, Macrocephaly and Eye development. The Heart disease study combines topics in areas such as Human genetics, Cohort and Copy-number variation.
His Gene research is multidisciplinary, relying on both Odds ratio and Confidence interval. His work carried out in the field of Noonan syndrome brings together such families of science as Gestational age, Bioinformatics, Cardiomyopathy, Hypertrophic cardiomyopathy and Germline. His Disease study incorporates themes from Human physiology, Risk analysis and Patient care.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome.
Marco Tartaglia;Marco Tartaglia;Ernest L. Mehler;Rosalie Goldberg;Giuseppe Zampino.
Nature Genetics (2001)
Pycnodysostosis, a Lysosomal Disease Caused by Cathepsin K Deficiency
Bruce D. Gelb;Guo-Ping Shi;Harold A. Chapman;Robert J. Desnick.
Science (1996)
Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia
Marco Tartaglia;Charlotte M Niemeyer;Alessandra Fragale;Alessandra Fragale;Xiaoling Song.
Nature Genetics (2003)
Genetic Basis for Congenital Heart Defects: Current Knowledge A Scientific Statement From the American Heart Association Congenital Cardiac Defects Committee, Council on Cardiovascular Disease in the Young
Mary Ella M Pierpont;Craig T. Basson;D. Woodrow Benson;Bruce D. Gelb.
Circulation (2007)
De novo mutations in histone-modifying genes in congenital heart disease
Samir Zaidi;Murim Choi;Hiroko Wakimoto;Lijiang Ma.
Nature (2013)
PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity
Marco Tartaglia;Marco Tartaglia;Kamini Kalidas;Adam Shaw;Xiaoling Song.
American Journal of Human Genetics (2002)
Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome
Xonia Carvajal-Vergara;Ana Sevilla;Sunita L. Dsouza;Yen Sin Ang.
Nature (2010)
Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy
Bhaswati Pandit;Anna Sarkozy;Len A Pennacchio;Claudio Carta.
Nature Genetics (2007)
Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome
Marco Tartaglia;Len A Pennacchio;Len A Pennacchio;Chen Zhao;Kamlesh K Yadav.
Nature Genetics (2007)
Noonan Syndrome: Clinical Features, Diagnosis, and Management Guidelines
Alicia A. Romano;Judith E. Allanson;Jovanna Dahlgren;Bruce D. Gelb.
Pediatrics (2010)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Boston Children's Hospital
Harvard University
Icahn School of Medicine at Mount Sinai
Columbia University
Boston Children's Hospital
Rockefeller University
Harvard University
Otto-von-Guericke University Magdeburg
Lawrence Berkeley National Laboratory
Boston Children's Hospital
Yale University
Korea University
University of Cambridge
University of Parma
The Ohio State University
Technical University of Munich
Argonne National Laboratory
University of Science and Technology of China
Bayer (Germany)
Fox Chase Cancer Center
York University
University of Zaragoza
Tohoku University
University of Houston
Stony Brook University
Indiana University